Results 111 to 120 of about 444,854 (202)

Unraveling Heart Inflammation: Recurrent Myopericarditis Caused by Coxsackie A Virus—A Case Report

Clinical Case Reports
Acute recurrent myopericarditis, characterized by the occurrence of a new myopericarditis event following a symptom‐free interval of 4–6 weeks, is relatively rare lacking definitive guidelines for management.
Maisha Maliha, Vikyath Satish, Kuan Yu Chi, Nishat Shama, Sananda Halder, Sumaiya Monjur Oishy, Amrin Kharawala, Dimitrios Varrias, Robert T. Fallaice   +8 more
doaj   +1 more source

Recurrent pericarditis: the importance of guideline-based treatment for reducing recurrences. A single centre experience.

reservedIntroduction: Acute pericarditis, while generally considered a benign disease, may relapse in a sizable proportion of cases. Although innovative therapies, such as anti-IL1 drugs, have emerged as promising treatment options, the criteria for ...
BOCAJ, IRIS
core  

Immunosuppressive therapy prevents development of recurrent pericarditis

, 1995
OBJECTIVES: This study reviews the clinical outcome of a series of patients with recurrent pericarditis before and after immunosuppressive therapy.
LAVEDER F, AGOSTINI, CARLO, GASPAROTTO G, MARCOLONGO R, RUSSO R, NOVENTA F   +5 more
core  

P118 | Long term outcome and disease duration in patients treated with anti-IL 1 drugs for recurrent pericarditis: ad interim analysis of a longitudinal study

Italian Journal of Medicine
Background: Although anti-IL 1 drugs have been proven effective in treating recurrent pericarditis, there is a lack of data about their long-term follow-up. Objectives: To evaluate the percentage of patients with recurrent pericarditis treated with anti-
doaj   +1 more source

Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology ...
Massimo Imazio, Allan L. Klein, Antonio Brucato, Antonio Abbate, Michael Arad, Paul C. Cremer, Antonella Insalaco, Martin M. LeWinter, Basil S. Lewis, David Lin, Sushil A. Luis, Stephen J. Nicholls, Paul Sutej, Yishay Wasserstrum, JoAnn Clair, Indra Agarwal, Sheldon Wang, John F. Paolini   +17 more
doaj   +1 more source

Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences

Cardiology Research and Practice, 2019
Pericarditis is a common disease, often postviral or “idiopathic,” diagnosed in about 5% of emergency room visits for non-ischemic chest pain. Although pericarditis often occurs as a benign and self-limiting disease, it may present recurrences. The first-
Antonio Perrone, Anna Castrovilli, Giuseppina Piazzolla, Sabina Savino, Alessia D’Introno, Carlo Sabbà   +5 more
doaj   +1 more source

The tale of refractory recurrent pericarditis

Internal and Emergency Medicine, 2021
George Lazaros, Alexios Antonopoulos, Emilia Lazarou, Charalambos Vlachopoulos, Konstantinos Tsioufis   +4 more
openaire   +3 more sources

Pathogenesis, management, and prevention of recurrent pericarditis

, 2007
Recurrent pericarditis is one of the most troublesome complications of acute pericarditis and, despite recent advances, remains one of the most challenging problems in pericardial diseases.
Shabetai R, Imazio M, Trinchero R
core  

Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis

, 2020
Nonsteroidal anti-inflammatory drugs and colchicine remain the standard of care as the initial treatment of acute pericarditis. Corticosteroids and traditional immunosuppressive medications are often added if patients develop recurrent symptoms and ...
Verma B. R., Khayata M., Giugni A. S., Imazio M., Klein A. L., Shah N. P., Asher C. R., Alkharabsheh S.   +7 more
core   +1 more source

Recurrent pericarditis. [PDF]

BMJ, 1968
J, Robinson, W, Brigden
openaire   +2 more sources